fructosamine has been researched along with insulin glargine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Derobert, E; Eugène-Jolchine, I; Pieber, TR | 1 |
| Bode, BW; Garg, S; Hirsch, IB; Hu, P; Kolaczynski, JW; Lane, WS; Santiago, OM; Sussman, A | 1 |
| Bayram, F; Cesur, M; Corapcioglu, D; Emral, R; Gonen, S; Gursoy, A; Kamel, N; Ozduman, M; Tonyukuk, V; Uysal, AR; Yilmaz, AE | 1 |
| Aste, G; Boari, A; Dalessandri, A; Rocconi, F; Vita, S | 1 |
| Bakiner, O; Bozkirli, E; Demirag, NG; Ertorer, ME; Tutuncu, NB | 1 |
| Freeman, LM; Hall, TD; Mahony, O; Rozanski, EA | 1 |
| Bertrand, JH; Catargi, B; Douard, H; Feige, JM; Fischbach, M; Iliou, MC; Patois-Vergès, B; Simoneau-Robin, I; Vergès, B | 1 |
| Bannasch, MJ; Delpero, A; Gilor, C; Hulsebosch, SE; Lancaster, T; Murikipudi, S; Pires, J; Ragupathy, R; Zion, T | 1 |
5 trial(s) available for fructosamine and insulin glargine
| Article | Year |
|---|---|
Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemia; Insulin; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Male; Middle Aged; Safety; Single-Blind Method | 2000 |
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
Topics: Adult; Biomarkers; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 1; Drug Administration Schedule; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Insulin Aspart; Insulin Glargine; Insulin Infusion Systems; Insulin, Long-Acting; Male | 2005 |
Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine.
Topics: Animals; Blood Glucose; Cat Diseases; Cats; Diabetes Mellitus; Diet, Carbohydrate-Restricted; Diet, Diabetic; Dietary Carbohydrates; Dietary Proteins; Female; Fructosamine; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Treatment Outcome | 2009 |
Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study.
Topics: Acute Coronary Syndrome; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Exercise Therapy; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Aspart; Insulin Glargine; Male; Metformin; Middle Aged; Oxygen Consumption; Pulmonary Gas Exchange; Pulmonary Ventilation; Treatment Outcome | 2015 |
Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs.
Topics: Animals; Blood Glucose; Blood Glucose Self-Monitoring; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dog Diseases; Dogs; Fructosamine; Hospitals, Animal; Hospitals, Teaching; Hypoglycemic Agents; Insulin; Insulin Glargine; Prospective Studies | 2022 |
3 other study(ies) available for fructosamine and insulin glargine
| Article | Year |
|---|---|
A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting.
Topics: Adult; Body Mass Index; Carbamates; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Islam; Male; Middle Aged; Patient Selection; Piperidines; Sulfonylurea Compounds; Turkey | 2007 |
Glargine insulin and high-protein-low-carbohydrate diet in cats with diabetes mellitus.
Topics: Animals; Animals, Domestic; Cat Diseases; Cats; Diabetes Mellitus, Type 2; Diet, Carbohydrate-Restricted; Diet, Diabetic; Fructosamine; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting | 2008 |
Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Blood Pressure; Carbamates; Diabetes Mellitus, Type 2; Drug Administration Schedule; Fasting; Female; Fructosamine; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Islam; Male; Middle Aged; Patient Selection; Piperidines; Risk Assessment; Safety; Turkey | 2009 |